Monte Rosa Therapeutics Statistics
Total Valuation
GLUE has a market cap or net worth of $1.28 billion. The enterprise value is $947.14 million.
Important Dates
The last earnings date was Tuesday, March 17, 2026, before market open.
| Earnings Date | Mar 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
GLUE has 80.02 million shares outstanding. The number of shares has increased by 12.40% in one year.
| Current Share Class | 80.02M |
| Shares Outstanding | 80.02M |
| Shares Change (YoY) | +12.40% |
| Shares Change (QoQ) | +3.82% |
| Owned by Insiders (%) | 0.59% |
| Owned by Institutions (%) | 60.29% |
| Float | 57.22M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.39 |
| Forward PS | 98.23 |
| PB Ratio | 4.42 |
| P/TBV Ratio | 5.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.66 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.12, with a Debt / Equity ratio of 0.17.
| Current Ratio | 6.12 |
| Quick Ratio | 6.05 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -16.94% and return on invested capital (ROIC) is -12.60%.
| Return on Equity (ROE) | -16.94% |
| Return on Assets (ROA) | -7.64% |
| Return on Invested Capital (ROIC) | -12.60% |
| Return on Capital Employed (ROCE) | -14.10% |
| Weighted Average Cost of Capital (WACC) | 12.87% |
| Revenue Per Employee | $824,480 |
| Profits Per Employee | -$257,507 |
| Employee Count | 150 |
| Asset Turnover | 0.28 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.10M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +179.72% in the last 52 weeks. The beta is 1.64, so GLUE's price volatility has been higher than the market average.
| Beta (5Y) | 1.64 |
| 52-Week Price Change | +179.72% |
| 50-Day Moving Average | 19.06 |
| 200-Day Moving Average | 11.94 |
| Relative Strength Index (RSI) | 40.68 |
| Average Volume (20 Days) | 1,232,978 |
Short Selling Information
The latest short interest is 10.12 million, so 12.64% of the outstanding shares have been sold short.
| Short Interest | 10.12M |
| Short Previous Month | 9.33M |
| Short % of Shares Out | 12.64% |
| Short % of Float | 17.68% |
| Short Ratio (days to cover) | 9.73 |
Income Statement
In the last 12 months, GLUE had revenue of $123.67 million and -$38.63 million in losses. Loss per share was -$0.46.
| Revenue | 123.67M |
| Gross Profit | -10.03M |
| Operating Income | -54.21M |
| Pretax Income | -39.72M |
| Net Income | -38.63M |
| EBITDA | -45.85M |
| EBIT | -54.21M |
| Loss Per Share | -$0.46 |
Full Income StatementBalance Sheet
The company has $377.10 million in cash and $39.19 million in debt, with a net cash position of $337.91 million or $4.22 per share.
| Cash & Cash Equivalents | 377.10M |
| Total Debt | 39.19M |
| Net Cash | 337.91M |
| Net Cash Per Share | $4.22 |
| Equity (Book Value) | 233.06M |
| Book Value Per Share | 3.56 |
| Working Capital | 328.97M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$22.80 million and capital expenditures -$4.70 million, giving a free cash flow of -$27.50 million.
| Operating Cash Flow | -22.80M |
| Capital Expenditures | -4.70M |
| Depreciation & Amortization | 8.36M |
| Net Borrowing | n/a |
| Free Cash Flow | -27.50M |
| FCF Per Share | -$0.34 |
Full Cash Flow StatementMargins
Gross margin is -8.11%, with operating and profit margins of -43.83% and -31.23%.
| Gross Margin | -8.11% |
| Operating Margin | -43.83% |
| Pretax Margin | -32.12% |
| Profit Margin | -31.23% |
| EBITDA Margin | -37.08% |
| EBIT Margin | -43.83% |
| FCF Margin | n/a |
Dividends & Yields
GLUE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.40% |
| Shareholder Yield | -12.40% |
| Earnings Yield | -3.01% |
| FCF Yield | -2.14% |
Analyst Forecast
The average price target for GLUE is $32.00, which is 100.75% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $32.00 |
| Price Target Difference | 100.75% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 10.54% |
| EPS Growth Forecast (5Y) | 18.83% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
GLUE has an Altman Z-Score of 0.56 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.56 |
| Piotroski F-Score | 4 |
